Plan your trading with the latest market research on Crypto, Forex, Stocks, and more, from our team of experts.
Early last week, the markets stabilized as no new bank announced that they were in dire straits ever since Credit…
Crypto prices made their most significant weekly increase since July 2021 last week after the US PPI index came in…
Stocks had their worst week since June 2022 on the back of several factors last week. The negativity started after…
The week for crypto came with many negative news out of the USA, first with credit card giants Visa and…
News from Hong Kong that it would legalize the trading of cryptocurrencies in the city-state caused prices of China-related tokens…
Last week’s economic numbers out of the USA came in largely stronger than expected, with inflation gauges revealing that the…
Early last week on Tuesday, Fed Chair Powell again reiterated the same thing he said in the post Fed meeting…
The week began with positive outlook guidance from China and even the IMF. First off, China’s improving manufacturing numbers gave…
US stocks had a good week after Q42022 GDP figures came in better than expected, rising 2.9% versus expectation of…
Stocks rallied for the second week in a row in the new year 2023, with tamer CPI numbers out of…
Friday’s non-farm payrolls beat gave stocks a great positive start to the year 2023 as US indices rallied in the…
The BoJ jolted markets with a revision of its yield curve control (YCC), sending the yen surging by more than…
As expected, the Fed hiked interest rates by 50-bps last Wednesday. However, the key issue that markets had trouble with…
In a quiet week with not much on the calendar, stocks closed lower as traders realign their positions ahead of…
The information provided here is not an invitation to buy or sell products, nor is it an invitation to make an investment or trading strategy. This should not be seen as financial or investment advice of any kind, nor does Prime XBT endorse or guarantee the relevance, timeliness, or accuracy of the information or publications.
Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.
